Therapeutic Asset Ratings
204 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Vinorelbine
ER Positive Breast Cancer
Massachusetts General Hospital
P2
BB
(64)
PBR28
Multiple Sclerosis
Massachusetts General Hospital
P4
B
(63)
Setmelanotide
Obesity
Massachusetts General Hospital
P3
B
(63)
Trastuzumab Emtansine
Invasive Breast Carcinoma
Massachusetts General Hospital
P3
B
(63)
Buspirone
Brain Injuries, Traumatic
Massachusetts General Hospital
P4
B
(62)
Buspirone
Depression
Massachusetts General Hospital
P4
B
(62)
FILGRASTIM
Glioblastoma
Massachusetts General Hospital
P3
B
(62)
Crizotinib
Refractory Malignant Solid Neoplasm
Massachusetts General Hospital
P2
B
(61)
FLUDEOXYGLUCOSE
Prostate Adenocarcinoma
Massachusetts General Hospital
P2/3
B
(61)
17-beta-estradiol
NASH - Nonalcoholic Steatohepatitis
Massachusetts General Hospital
P3
B
(60)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Metastatic Colon Cancer
Massachusetts General Hospital
P3
B
(60)
Nivolumab
Metastatic Colon Cancer
Massachusetts General Hospital
P3
B
(60)
RDX-013 COMPONENT TENAPANOR
Constipation
Massachusetts General Hospital
P3
B
(60)
TRASTUZUMAB
Metastatic Colon Cancer
Massachusetts General Hospital
P3
B
(60)
Losartan
Radiation Fibrosis
Massachusetts General Hospital
P2
B
(60)
Nivolumab
Metastatic Cancer Colorectal
Massachusetts General Hospital
P2
B
(60)
Nivolumab
Smoldering Multiple Myeloma
Massachusetts General Hospital
P2
B
(60)
Lurasidone
Depression
Massachusetts General Hospital
P4
B
(59)
Binimetinib
Metastatic Colon Cancer
Massachusetts General Hospital
P3
B
(58)
Encorafenib
Metastatic Colon Cancer
Massachusetts General Hospital
P3
B
(58)
Eovist
Hepatocellular Carcinoma
Massachusetts General Hospital
P4
B
(57)
Capecitabine
PR-Positive Breast Cancer
Massachusetts General Hospital
P2
B
(57)
FULVESTRANT
Progesterone Receptor-positive Breast Cancer
Massachusetts General Hospital
P2
B
(57)
Lum-201
NAFLD
Massachusetts General Hospital
P2
B
(57)
Lum-201
NASH - Nonalcoholic Steatohepatitis
Massachusetts General Hospital
P2
B
(57)
Showing 26 to 50 of 204 assets
Previous
Page 2 of 9
Next